New Approach Methodologies (NAMs) are transforming the landscape of biomedical research by offering innovative, ethical, and more human-relevant alternatives to traditional animal testing. These methods include advanced in vitro systems, organ-on-chip technologies, computational models, and the use of human-derived data.
In Switzerland, a country known for its excellence in life sciences and precision medicine, the integration of NAMs is gaining momentum across academia, industry, and regulatory bodies. With strong institutional support and a commitment to the 3Rs (Replacement, Reduction, and Refinement of animal use), Swiss researchers are pioneering applications that improve translational relevance and efficiency in biomedical studies.
Why Attend:
• Gain insights into cutting-edge NAMs and their applications
• Network with leading experts and stakeholders in the field
• Explore collaborative opportunities within Switzerland
Who Should Attend:
• Biomedical and clinical researchers
• Regulatory affairs professionals
• Healthcare industry stakeholders
• Academic and research institutions
• Policy makers and government agencies
Confirmed Speakers:
• Robert Katzschmann, Soft Robotics Lab, ETH Zürich
• Marianna Kruithof-de Julio, Translational Organoid Resource (TOR), University of Bern
• Magdalena Renner, Institute of Molecular and Clinical Ophthalmology, Basel
• Gaspard Pardon, AGORA Cancer Research Center Bioengineering & Organoids Technology Platform
Grüentalstrasse 14, 8820 Wädenswil, Switzerland
Biotechnet Switzerland c/o FHNW School of Life Sciences, Hofackerstrasse 30, 4132 Muttenz, Switzerland
Copyright 2026, Raskin Apps and Biotechnet